Lukas Biomedical Inc. (6814.TWO)
TWD 30.05
(0.0%)
TWD 30.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -47.35 Million TWD | 5.43% |
| 2022 | -50.07 Million TWD | -1.16% |
| 2021 | -49.49 Million TWD | -369.49% |
| 2020 | -10.54 Million TWD | -50.84% |
| 2019 | -6.98 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -20.33 Million TWD | 0.0% |
| 2024 Q1 | -20.33 Million TWD | -24.56% |
| 2023 Q3 | -16.32 Million TWD | -122.02% |
| 2023 Q1 | -7.35 Million TWD | 37.0% |
| 2023 Q2 | -7.35 Million TWD | 0.0% |
| 2023 Q4 | -16.32 Million TWD | 0.0% |
| 2022 FY | -50.07 Million TWD | -1.16% |
| 2022 Q4 | -11.67 Million TWD | 0.0% |
| 2021 FY | -49.49 Million TWD | -369.49% |
| 2020 FY | -10.54 Million TWD | -50.84% |
| 2019 FY | -6.98 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 35.385% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 71.825% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 48.591% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 78.23% |
| NaviFUS Corp. | -65.72 Million TWD | 27.957% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 165.405% |
| TaiRx, Inc. | -212.29 Million TWD | 77.694% |
| Sinew Pharma Inc. | -170.92 Million TWD | 72.295% |
| Lin BioScience, Inc. | -687.19 Million TWD | 93.109% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -683.083% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 80.107% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 8.553% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 118.865% |
| AP Biosciences Inc | -339.29 Million TWD | 86.044% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 107.568% |
| RBC Bioscience Corporation | 6.43 Million TWD | 836.439% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 117.23% |
| EirGenix Inc. | -915.2 Million TWD | 94.826% |
| Enimmune corporation | -223.74 Million TWD | 78.836% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 93.118% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 18.288% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 75.693% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 93.065% |
| TCI GENE Inc. | 11.67 Million TWD | 505.663% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -24.052% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 96.393% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 8.254% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 307.761% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 26.749% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 72.257% |
| Neith Corporation | -40.03 Million TWD | -18.285% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 25.216% |
| VBI | -6.6 Million TWD | -617.361% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 108.779% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 71.52% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -27.413% |
| CHO Pharma, Inc. | -306.08 Million TWD | 84.53% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 30.526% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 62.874% |
| Visgeneer Inc. | -19.58 Million TWD | -141.733% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 136.24% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 195.195% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 46.244% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 13.965% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 69.709% |
| GlycoNex Incorporation | -178.36 Million TWD | 73.451% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 91.564% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 659.993% |
| PharmaEngine, Inc. | 274.65 Million TWD | 117.241% |
| Intech Biopharm Corporation | -337.98 Million TWD | 85.99% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -343.297% |
| BiOptic Inc. | 37.74 Million TWD | 225.448% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 134.632% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 84.019% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 567.915% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 95.475% |
| Savior Lifetec Corporation | 30.03 Million TWD | 257.686% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 23.053% |
| Level Biotechnology Inc. | 62.9 Million TWD | 175.277% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 95.917% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 62.222% |
| Acepodia, Inc. | -817.31 Million TWD | 94.206% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 90.306% |